These drugs represent only the first primitive, halting generation of cognitive enhancers. Memory drugs will soon make it to market if human clinical trials continue successfully.
There are lots of the first-generation drugs around. Total sales have increased by more than 300 percent in only four years, topping $3.6 billion last year, according to IMS Health, a pharmaceutical information company. They include Adderall, which was originally aimed at people with attention-deficit disorder, and Provigil, which was aimed at narcoleptics, who fall asleep uncontrollably. In the healthy, this class of drugs variously aids concentration, alertness, focus, short-term memory and wakefulness — useful qualities in students working on complex term papers and pulling all-nighters before exams. Adderall sales are up 3,135.6 percent over the same period. Provigil is up 359.7 percent.
Adderall helps memory in mice by about 20-50%.
Genetic engineering, gene therapy could replace steroids for muscle enhancement without side effects and that could be possible for memory and intelligence enhancement as well.
Brian Wang is a Futurist Thought Leader and a popular Science blogger with 1 million readers per month. His blog Nextbigfuture.com is ranked #1 Science News Blog. It covers many disruptive technology and trends including Space, Robotics, Artificial Intelligence, Medicine, Anti-aging Biotechnology, and Nanotechnology.
Known for identifying cutting edge technologies, he is currently a Co-Founder of a startup and fundraiser for high potential early-stage companies. He is the Head of Research for Allocations for deep technology investments and an Angel Investor at Space Angels.
A frequent speaker at corporations, he has been a TEDx speaker, a Singularity University speaker and guest at numerous interviews for radio and podcasts. He is open to public speaking and advising engagements.